Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

PURPOSE: Twenty percent of patients with follicular lymphoma (FL) experience progression of disease (POD) within 2 years of initial chemoimmunotherapy. We analyzed data from the National LymphoCare Study to identify whether prognostic FL factors are associated with early POD and whether patients wit...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Oncol
Prif Awduron: Casulo, Carla, Byrtek, Michelle, Dawson, Keith L., Zhou, Xiaolei, Farber, Charles M., Flowers, Christopher R., Hainsworth, John D., Maurer, Matthew J., Cerhan, James R., Link, Brian K., Zelenetz, Andrew D., Friedberg, Jonathan W.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2015
Pynciau:
ORIGINAL REPORTS
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879714/
https://ncbi.nlm.nih.gov/pubmed/26124482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.59.7534
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg